Sensidose AB

Sensidose AB is a Swedish pharmaceutical company based in Solna that developed an innovative system for individualized dosing of medicines in minitablets. Its product Flexilev is a prescription drug in minitablet form for advanced Parkinson's disease, administered with the individually programmable MyFID dosing device. The system allows fine-tuned dose adjustment and targets mainly Parkinson's, as well as pain, diabetes and epilepsy. Since May 2023 operates as a subsidiary of Norwegian Navamedic ASA (acquired for SEK 75M).